A nonlinear relationship between dietary inflammatory index and stroke among US adults with metabolic dysfunction-associated steatotic liver disease

被引:1
|
作者
Guo, Renwei [1 ]
Du, Juan [2 ]
机构
[1] Xuzhou Med Univ, Xuzhou Cent Hosp, Xuzhou Clin Sch, Dept Gastroenterol, Xuzhou, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Xuzhou Cent Hosp, Xuzhou Clin Sch, Dept Neurol, Xuzhou 221006, Jiangsu, Peoples R China
关键词
cross-sectional study; dietary inflammatory index; metabolic dysfunction-associated steatotic liver disease; stroke; NATIONAL-HEALTH; RISK;
D O I
10.1097/MEG.0000000000002876
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundSome studies have found that high dietary inflammatory index (DII) increases stroke risk, but previous studies have mostly been conducted in the general population, and the exact relationship between DII and stroke in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) is not clear.MethodsThis cross-sectional study utilized data from the National Health and Nutrition Examination Survey (2009-2016) to investigate the association between the DII and stroke. DII was computed according to established methods. Participants were categorized into tertiles of DII (Q1-Q3). Multivariate weighted logistic regression analysis, smooth curve fitting, and subgroup analysis were employed to explore this relationship. Subgroup analyses were conducted based on demographic and clinical variables.ResultsA total of 2426 individuals were enrolled in our study. The overall prevalence of stroke in the study population was 4.66%. The smooth curve fitting analysis indicated a J-shaped relationship between DII and stroke among individuals with MASLD. In multivariate weighted logistic regression analysis, the odds ratio (OR) of DII is 1.17 (95% CI: 1.03-1.38) for stroke, with a turning point of 1.89. After the turning point, the OR (95% CI) was 1.22 (1.08-2.56). In subgroup analysis, DII still increased the risk of stroke independently.ConclusionOur study highlighted a J-shaped association between DII and stroke in adults with MASLD from USA.
引用
收藏
页码:272 / 278
页数:7
相关论文
共 50 条
  • [41] The associations between fibrosis changes and liver-related events in patients with metabolic dysfunction-associated steatotic liver disease
    Lee, Hye Won
    Kim, Kun Hee
    Ahn, Sang Hoon
    Lee, Han Chu
    Choi, Jonggi
    LIVER INTERNATIONAL, 2024, 44 (06) : 1448 - 1455
  • [42] Metabolic Dysfunction-Associated Steatotic Liver Disease and Polycystic Ovary Syndrome: A Complex Interplay
    Arvanitakis, Konstantinos
    Chatzikalil, Elena
    Kalopitas, Georgios
    Patoulias, Dimitrios
    Popovic, Djordje S.
    Metallidis, Symeon
    Kotsa, Kalliopi
    Germanidis, Georgios
    Koufakis, Theocharis
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (14)
  • [43] A narrative review of lifestyle management guidelines for metabolic dysfunction-associated steatotic liver disease
    Wajcman, Dana Ivancovsky
    Byrne, Christopher J.
    Dillon, John F.
    Brennan, Paul N.
    Villota-Rivas, Marcela
    Younossi, Zobair M.
    Allen, Alina M.
    Crespo, Javier
    Gerber, Lynn H.
    Lazarus, Jeffrey V.
    HEPATOLOGY, 2024,
  • [44] The Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B
    Patmore, Lesley A.
    van Eekhout, Kirsi
    Koc, oezguer M.
    de Knegt, Robert J.
    Janssen, Harry L. A.
    Brouwer, Willem P.
    Kramer, Matthijs
    Honkoop, Pieter
    de Bruijne, Joep
    Boland, Greet J.
    Postma, Douwe F.
    Blokzijl, Hans
    de Man, Robert A.
    Takkenberg, R. Bart
    Sonneveld, Milan J.
    LIVER INTERNATIONAL, 2025, 45 (03)
  • [45] Celiac Disease, Gluten-Free Diet and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Cazac, Georgiana-Diana
    Mihai, Bogdan-Mircea
    Stefanescu, Gabriela
    Gilca-Blanariu, Georgiana-Emmanuela
    Mihai, Catalina
    Grigorescu, Elena-Daniela
    Onofriescu, Alina
    Lacatusu, Cristina-Mihaela
    NUTRIENTS, 2024, 16 (13)
  • [46] Sleep Duration, Midpoint, Variability, Irregularity and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Wu, Qingcui
    Song, Fuman
    Huang, Huijie
    Wang, Siting
    Zhang, Naijian
    Li, Zhilin
    Liu, Yuanyuan
    Chen, Jiageng
    Ma, Jun
    BEHAVIORAL SLEEP MEDICINE, 2025, : 400 - 413
  • [47] High sensitivity troponins and mortality in the population with metabolic dysfunction-associated steatotic liver disease
    Hu, Jingjing
    Du, Yuteng
    Zhou, Yidan
    Wang, Huiying
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [48] A Healthful Plant-Based Diet as an Alternative Dietary Approach in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
    Castelnuovo, Gabriele
    Perez-Diaz-del-Campo, Nuria
    Rosso, Chiara
    Armandi, Angelo
    Caviglia, Gian Paolo
    Bugianesi, Elisabetta
    NUTRIENTS, 2024, 16 (13)
  • [49] Association of dietary inflammatory index with sarcopenia in patients with Metabolic dysfunction-associated fatty liver disease: a cross-sectional study
    Wang, Xianyao
    Shi, Rongjie
    Zi, Ying
    Long, Jun
    FRONTIERS IN NUTRITION, 2024, 11
  • [50] Association between serum per- and polyfluoroalkyl substances levels and metabolic dysfunction-associated steatotic liver disease
    Zhang, Jin
    Cheng, Xu
    Wang, Yu
    Guo, Hong
    Liu, Lin
    Liu, Lu
    Gao, Junya
    He, Meian
    ENVIRONMENTAL POLLUTION, 2024, 363